Innovative Smokerlyzer® and NObreath® respiratory devices to be exhibited at the European Respiratory Society International Congress.
Bedfont® Scientific Limited, world leaders in breath analysis, is attending the European Respiratory Society (ERS) International Congress to showcase its innovative Smokerlyzer® and NObreath® devices. The Smokerlyzer® measures exhaled carbon monoxide (CO) to support smoking cessation efforts, while the NObreath® assesses Fractional exhaled Nitric Oxide (FeNO) levels to aid in the diagnosis and management of asthma. The Bedfont® vision is a world where everyone has access to instant, non-invasive, simple breath testing to aid in medical diagnosis. At the congress, Bedfont® aims to attract the attention of healthcare experts and secure new distributors in the region to help achieve this.
Bedfont® has over 48 years of expertise and knowledge in the breath analysis industry, designing and manufacturing cutting-edge medical devices at affordable prices to improve accessibility and healthcare standards worldwide. The ERS Congress brings together respiratory experts from around the world to explore the latest advances in respiratory medicine and science. It takes place from September 27th to October 1st in Amsterdam, the Netherlands.
«We’re excited to be attending the ERS Congress this September to showcase our Smokerlyzer® and NObreath® devices. Events like this are invaluable opportunities to connect with healthcare professionals and industry leaders who share our commitment to advancing respiratory diagnostics. We’re also looking forward to building new relationships with distributors in the region as we continue to expand our global reach.” Said Jason Smith, CEO at Bedfont®.
Bedfont® work with a carefully selected network of over 100 distributors worldwide, bringing its innovative technology to every corner of the world. Set up on a strong foundation of core values, Bedfont® carefully selects distributors based on shared values. Every distributor is considered an extension of the Bedfont® Family and is fully supported and looked after throughout the partnership.
As a distributor of Bedfont®, you can expect to receive ongoing support through regular communication on device and company updates, full product training, comprehensive marketing resources, and complimentary educational content, including webinars hosted by Key Opinion Leaders (KOLs), as well as potential grants for marketing initiatives.
Additionally, regular face-to-face meetings are organised. The most recent get-together was held in 2024, when distributors from around the world were invited to the UK for a week of collaboration, including essential updates, in-person training, team-building activities, and distributor awards. While remote communication is becoming the norm, Bedfont® believes the in-person approach also helps build those crucial relationships.
You will find the friendly Bedfont® team on stand D.13 at this year’s ERS Congress, offering demonstrations of the innovative Smokerlyzer® CO monitoring devices as well as the NObreath® FeNO device. For more information on these devices, visit the website here.
If you are interested in becoming a distributor of Bedfont® products, please visit the Become a Distributor page here.
